Transmitted from animals to humans by the tsetse fly
Distributed in west and central African
Few early symptoms, followed by fever, headache, and deterioration of the CNS
Parasite evades antibodies through antigenic variation
Difficult for vaccine development
Treated with eflornithine: crosses the blood-brain barrier; blocks an enzyme necessary for the parasite
Prevention: elimination of tsetse fly vectors